Hunter syndrome (MPS II) involves iduronate 2-sulfatase (IDS), a key enzyme of the lysosomal dermatan and heparan sulfate degradation pathway (Demydchuk et al., 2017; Platt et al., 2018). This evidence concerns the gene IDS and mucopolysaccharidosis type 2.